{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:17:11Z","timestamp":1783509431102,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"DOI":"10.1007\/s00240-026-02025-x","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:40:51Z","timestamp":1783507251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world efficacy and safety of the CVAC 2.0 ureteroscope: results from a single-center retrospective study"],"prefix":"10.1007","volume":"54","author":[{"given":"Nathaniel Fox","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Labeeqa","family":"Khizir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron H.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Haleblian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Wollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"5","key":"2025_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.euf.2023.03.010","volume":"9","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Daignault-Newton S, DiBianco JM et al (2023) Real-world Practice Stone-free Rates After Ureteroscopy: Variation and Outcomes in a Surgical Collaborative. Eur Urol Focus 9(5):773\u2013780. https:\/\/doi.org\/10.1016\/j.euf.2023.03.010","journal-title":"Eur Urol Focus"},{"key":"2025_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.urology.2018.09.005","volume":"124","author":"NE York","year":"2019","unstructured":"York NE, Zheng M, Elmansy HM, Rivera ME, Krambeck AE, Lingeman JE (2019) Stone-free Outcomes of Flexible Ureteroscopy for Renal Calculi Utilizing Computed Tomography Imaging. Urology 124:52\u201356. https:\/\/doi.org\/10.1016\/j.urology.2018.09.005","journal-title":"Urology"},{"issue":"4 Pt 1","key":"2025_CR3","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.juro.2015.11.009","volume":"195","author":"BH Chew","year":"2016","unstructured":"Chew BH, Brotherhood HL, Sur RL et al (2016) Natural History, Complications and Re-Intervention Rates of Asymptomatic Residual Stone Fragments after Ureteroscopy: a Report from the EDGE Research Consortium. J Urol 195(4 Pt 1):982\u2013986. https:\/\/doi.org\/10.1016\/j.juro.2015.11.009","journal-title":"J Urol"},{"issue":"1","key":"2025_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1089\/end.2017.0618","volume":"32","author":"AS Emmott","year":"2018","unstructured":"Emmott AS, Brotherhood HL, Paterson RF, Lange D, Chew BH, Complications (2018) Re-Intervention Rates, and Natural History of Residual Stone Fragments After Percutaneous Nephrolithotomy. J Endourol 32(1):28\u201332. https:\/\/doi.org\/10.1089\/end.2017.0618","journal-title":"J Endourol"},{"issue":"12","key":"2025_CR5","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1089\/end.2024.0435","volume":"38","author":"D Zhu","year":"2024","unstructured":"Zhu D, Mali K, Carlisi C et al (2024) Impact of Residual Stone Fragments on Risk of Unplanned Stone Events Following Percutaneous Nephrolithotomy. J Endourol 38(12):1380\u20131386. https:\/\/doi.org\/10.1089\/end.2024.0435","journal-title":"J Endourol"},{"issue":"1","key":"2025_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/end.2024.0602","volume":"39","author":"BR Matlaga","year":"2025","unstructured":"Matlaga BR, Mueller TJ, Johnson B et al (2025) A Prospective, Randomized, Noninferiority Study to Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation Compared with Standard Ureteroscopy: 30-Day Results of the ASPIRE Study. J Endourol 39(1):10\u201318. https:\/\/doi.org\/10.1089\/end.2024.0602","journal-title":"J Endourol"},{"key":"2025_CR7","doi-asserted-by":"publisher","first-page":"101097JU0000000","DOI":"10.1097\/JU.0000000000004842","volume":"20","author":"MS Pearle","year":"2025","unstructured":"Pearle MS, Matlaga BR, Antonelli JA et al (2025) Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026) Part I: Evaluation and Treatment of Patients with Kidney and\/or Ureteral Stones. J Urol Published online November 20:101097JU0000000000004842. https:\/\/doi.org\/10.1097\/JU.0000000000004842","journal-title":"J Urol Published online November"},{"issue":"1","key":"2025_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1590\/S1677-5538.IBJU.2014.01.04","volume":"40","author":"WR Molina","year":"2014","unstructured":"Molina WR, Kim FJ, Spendlove J, Pompeo AS, Sillau S, Sehrt DE (2014) The S.T.O.N.E. Score: a new assessment tool to predict stone free rates in ureteroscopy from pre-operative radiological features. Int Braz J Urol Off J Braz Soc Urol 40(1):23\u201329. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2014.01.04","journal-title":"Int Braz J Urol Off J Braz Soc Urol"},{"issue":"11","key":"2025_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/end.2023.0424","volume":"37","author":"KL Stern","year":"2023","unstructured":"Stern KL, Borgert BJ, Wolf JS (2023) Steerable Ureteroscopic Renal Evacuation (SURE) for Large Renal Stones: A Multi-Institutional Center Study. J Endourol 37(11):1179\u20131183. https:\/\/doi.org\/10.1089\/end.2023.0424","journal-title":"J Endourol"},{"issue":"1","key":"2025_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00345-025-05912-x","volume":"43","author":"CC Ballantyne","year":"2025","unstructured":"Ballantyne CC, Foss HE, Cabo JJ et al (2025) First in-vivo multicenter experience with the novel CVAC 2.0 ureteroscope with simultaneous irrigation and aspiration functionality. World J Urol 43(1):645. https:\/\/doi.org\/10.1007\/s00345-025-05912-x","journal-title":"World J Urol"},{"issue":"12","key":"2025_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/08927790251387343","volume":"39","author":"JJS Cabo","year":"2025","unstructured":"Cabo JJS, Ballantyne CC, Edmonds VS, Humphreys MR, Stern KL, Prospective (2025) Real-World Evaluation of CVAC 2.0 In-Scope Aspiration System Compared with Flexible and Navigable Ureteral Access Sheath for High-Volume Stone Disease. J Endourol 39(12):1215\u20131221. https:\/\/doi.org\/10.1177\/08927790251387343","journal-title":"J Endourol"},{"issue":"7","key":"2025_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1089\/end.2020.1133","volume":"35","author":"N Bhojani","year":"2021","unstructured":"Bhojani N, Miller LE, Bhattacharyya S, Cutone B, Chew BH (2021) Risk Factors for Urosepsis After Ureteroscopy for Stone Disease: A Systematic Review with Meta-Analysis. J Endourol 35(7):991\u20131000. https:\/\/doi.org\/10.1089\/end.2020.1133","journal-title":"J Endourol"},{"issue":"2","key":"2025_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MOU.0000000000000571","volume":"29","author":"R Suarez-Ibarrola","year":"2019","unstructured":"Suarez-Ibarrola R, Hein S, Miernik A (2019) Residual stone fragments: clinical implications and technological innovations. Curr Opin Urol 29(2):129\u2013134. https:\/\/doi.org\/10.1097\/MOU.0000000000000571","journal-title":"Curr Opin Urol"},{"issue":"3","key":"2025_CR14","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.juro.2008.10.162","volume":"181","author":"JD Raman","year":"2009","unstructured":"Raman JD, Bagrodia A, Gupta A et al (2009) Natural history of residual fragments following percutaneous nephrostolithotomy. J Urol 181(3):1163\u20131168. https:\/\/doi.org\/10.1016\/j.juro.2008.10.162","journal-title":"J Urol"},{"issue":"6","key":"2025_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/end.2022.0561","volume":"37","author":"VKF Wong","year":"2023","unstructured":"Wong VKF, Que J, Kong EK et al (2023) The Fate of Residual Fragments After Percutaneous Nephrolithotomy: Results from the Endourologic Disease Group for Excellence Research Consortium. J Endourol 37(6):617\u2013622. https:\/\/doi.org\/10.1089\/end.2022.0561","journal-title":"J Endourol"},{"key":"2025_CR16","unstructured":"Health C, for D, Early Alert R (2025) Aspiration System Issue from Calyxo. FDA. Published online March 20, 2025. Accessed December 23. https:\/\/www.fda.gov\/medical-devices\/medical-device-recalls-and-early-alerts\/early-alert-aspiration-system-issue-calyxo"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-026-02025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00240-026-02025-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-026-02025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:40:52Z","timestamp":1783507252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00240-026-02025-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1007\/s00240-026-02025-x","relation":{},"ISSN":["2194-7236"],"issn-type":[{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GH serves as an advisor for Calyxo, Inc which manufactures the CVAC 2.0 device.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}